Investors in Elevance Health, Inc. ELV need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $270Call had some of the highest implied ...

GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...

Elevance Health, Inc. (NYSE:ELV – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports.

Anthem offers Medicare Advantage plans providing Original Medicare Part A and Part B coverage, plus other benefits like ...

A Medicare Supplement—or Medigap—plan is an insurance plan that helps pay for gaps in coverage from Original Medicare. Anthem ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

Shares of Elevance Health Inc. ELV slid 1.24% to $391.22 Tuesday, on what proved to be an all-around positive trading session ...

CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...

This was the stock's second consecutive day of gains.

Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.